Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD - PubMed (original) (raw)
. 2005 Mar 1;105(5):2220-6.
doi: 10.1182/blood-2004-05-2044. Epub 2004 Nov 16.
Affiliations
- PMID: 15546950
- DOI: 10.1182/blood-2004-05-2044
Free article
Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD
Joerg Ermann et al. Blood. 2005.
Free article
Abstract
CD4+CD25+ regulatory T (Treg) cells are potent modulators of alloimmune responses. In murine models of allogeneic bone marrow transplantation, adoptive transfer of donor CD4+CD25+ Treg cells protects recipient mice from lethal acute graft-versus-host disease (aGVHD) induced by donor CD4+CD25- T cells. Here we examined the differential effect of CD62L+ and CD62L- subsets of CD4+CD25+ Treg cells on aGVHD-related mortality. Both subpopulations showed the characteristic features of CD4+CD25+ Treg cells in vitro and did not induce aGVHD in vivo. However, in cotransfer with donor CD4+CD25- T cells, only the CD62L+ subset of CD4+CD25+ Treg cells prevented severe tissue damage to the colon and protected recipients from lethal aGVHD. Early after transplantation, a higher number of donor-type Treg cells accumulated in host mesenteric lymph node (LN) and spleen when CD4+CD25+CD62L+ Treg cells were transferred compared with the CD62L- subset. Subsequently, CD4+CD25+CD62L+ Treg cells showed a significantly higher capacity than their CD62L- counterpart to inhibit the expansion of donor CD4+CD25- T cells. The ability of Treg cells to efficiently enter the priming sites of pathogenic allo-reactive T cells appears to be a prerequisite for their protective function in aGVHD.
Similar articles
- Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation.
Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S. Hoffmann P, et al. J Exp Med. 2002 Aug 5;196(3):389-99. doi: 10.1084/jem.20020399. J Exp Med. 2002. PMID: 12163567 Free PMC article. - Third-party regulatory T cells prevent murine acute graft-versus-host disease.
Lim JY, Im KI, Song Y, Kim N, Nam YS, Jeon YW, Cho SG. Lim JY, et al. Korean J Intern Med. 2018 Sep;33(5):980-989. doi: 10.3904/kjim.2016.319. Epub 2017 Oct 19. Korean J Intern Med. 2018. PMID: 29050459 Free PMC article. - Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality.
Schneidawind D, Baker J, Pierini A, Buechele C, Luong RH, Meyer EH, Negrin RS. Schneidawind D, et al. Blood. 2015 May 28;125(22):3491-500. doi: 10.1182/blood-2014-11-612762. Epub 2015 Mar 20. Blood. 2015. PMID: 25795920 Free PMC article. - Immune modulation of inflammatory conditions: regulatory T cells for treatment of GvHD.
Haase D, Starke M, Puan KJ, Lai TS, Rotzschke O. Haase D, et al. Immunol Res. 2012 Sep;53(1-3):200-12. doi: 10.1007/s12026-012-8267-9. Immunol Res. 2012. PMID: 22418725 Review. - Current status and perspectives of regulatory T cell-based therapy.
Qu G, Chen J, Li Y, Yuan Y, Liang R, Li B. Qu G, et al. J Genet Genomics. 2022 Jul;49(7):599-611. doi: 10.1016/j.jgg.2022.05.005. Epub 2022 May 28. J Genet Genomics. 2022. PMID: 35636740 Review.
Cited by
- CRISPR-GEM: A Novel Machine Learning Model for CRISPR Genetic Target Discovery and Evaluation.
Graham JP, Zhang Y, He L, Gonzalez-Fernandez T. Graham JP, et al. bioRxiv [Preprint]. 2024 Jul 3:2024.07.01.601587. doi: 10.1101/2024.07.01.601587. bioRxiv. 2024. PMID: 39005295 Free PMC article. Updated. Preprint. - Donor regulatory T cells rapidly adapt to recipient tissues to control murine acute graft-versus-host disease.
Dittmar DJ, Pielmeier F, Strieder N, Fischer A, Herbst M, Stanewsky H, Wenzl N, Röseler E, Eder R, Gebhard C, Schwarzfischer-Pfeilschifter L, Albrecht C, Herr W, Edinger M, Hoffmann P, Rehli M. Dittmar DJ, et al. Nat Commun. 2024 Apr 15;15(1):3224. doi: 10.1038/s41467-024-47575-z. Nat Commun. 2024. PMID: 38622133 Free PMC article. - Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity.
Santosh Nirmala S, Kayani K, Gliwiński M, Hu Y, Iwaszkiewicz-Grześ D, Piotrowska-Mieczkowska M, Sakowska J, Tomaszewicz M, Marín Morales JM, Lakshmi K, Marek-Trzonkowska NM, Trzonkowski P, Oo YH, Fuchs A. Santosh Nirmala S, et al. Front Immunol. 2024 Jan 12;14:1321228. doi: 10.3389/fimmu.2023.1321228. eCollection 2023. Front Immunol. 2024. PMID: 38283365 Free PMC article. Review. - Alpha-Synuclein-Specific Regulatory T Cells Ameliorate Parkinson's Disease Progression in Mice.
Park SY, Yang H, Kim S, Yang J, Go H, Bae H. Park SY, et al. Int J Mol Sci. 2023 Oct 16;24(20):15237. doi: 10.3390/ijms242015237. Int J Mol Sci. 2023. PMID: 37894917 Free PMC article. - Maternal dendritic cells influence fetal allograft response following murine in-utero hematopoietic stem cell transplantation.
Kandasamy K, Johana NB, Tan LG, Tan Y, Yeo JSL, Yusof NNB, Li Z, Koh J, Ginhoux F, Chan JKY, Choolani M, Mattar CNZ. Kandasamy K, et al. Stem Cell Res Ther. 2023 May 24;14(1):136. doi: 10.1186/s13287-023-03366-9. Stem Cell Res Ther. 2023. PMID: 37226255 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- AI-37683/AI/NIAID NIH HHS/United States
- CA-49605/CA/NCI NIH HHS/United States
- CA-65237/CA/NCI NIH HHS/United States
- CA-92225/CA/NCI NIH HHS/United States
- DK-61295/DK/NIDDK NIH HHS/United States
- HL-57443/HL/NHLBI NIH HHS/United States
- HL-58250/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials